Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody infliximab - A prospective study

被引：0
|
作者：
Lange, U
Teichmann, J
Strunk, J
机构：
[1] Kerckhoff Clin & Fdn, Bad Nauheim, Germany
[2] City Hosp Ludwigshafen, Ludwigshafen, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：443 / 444
页数：2
相关论文
共 50 条
  • [21] Effects of the TNF-alpha antibody infliximab on serum markers of bone turnover and mineral metabolism in patients with rheumatoid arthritis
    Dimai, HP
    Müller, T
    Eder, S
    Hermann, J
    BONE, 2001, 28 (05) : S179 - S180
  • [22] Changes in bone mineral density during anti-TNF alpha therapy in rheumatoid arthritis patients
    Ancuta, C.
    Chiriac, R.
    Ancuta, E.
    Iordache, C.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S106 - S107
  • [23] Anti-TNF-alpha antibody infliximab and glucocorticoids reduce serum vascular endothelial growth factor (VEGF) levels in patients with rheumatoid arthritis
    Strunk, J
    Heinemann, E
    Schmidt, KL
    Lange, U
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 249 - 249
  • [24] Infliximab increases bone mineral density in patients with rheumatoid arthritis
    Katherine Sole
    Nature Clinical Practice Rheumatology, 2006, 2 (3): : 120 - 120
  • [25] Infliximab, an anti-TNF-alpha agent, improves left atrial abnormalities in patients with rheumatoid arthritis: preliminary results
    Suha, Cetin
    Gokhan, Vural Mustafa
    Goksal, Keskin
    Ekrem, Yeter
    Mehmet, Dogan
    Akif, Ozturk Mehmet
    CARDIOVASCULAR JOURNAL OF AFRICA, 2014, 25 (04) : 168 - 175
  • [26] METHOTREXATE REDUCED TNF BIOACTIVITY BY ANTI-INFLIXIMAB ANTIBODY PREVENTION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB
    Denarie, D.
    Rinaudo, M.
    Thomas, T.
    Paul, S.
    Marotte, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 459 - 459
  • [27] Sensitivity to change of the omeract ramris score in patients with rheumatoid arthritis treated with anti-TNF-alpha therapy
    Haavardsholm, EA
    Ostergaard, M
    Shcildvold, A
    Kvien, TK
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 382 - 382
  • [28] Changes in bone mineral density under anti-TNF alpha therapy in rheumatoid arthritis
    Ancuta, C.
    Chirieac, R.
    Ancuta, E.
    Iordache, C.
    Tacu, C.
    Munteanu, C.
    Macovei, L.
    Nita, G.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S305 - S305
  • [29] EVALUATION OF CARDIOVASCULAR RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANTI-TNF-ALPHA THERAPY
    Anghel, D.
    Panturu, L.
    Jurcut, V. C.
    Muresan, M. M.
    Dilirici, E. L.
    Negru, M. M.
    Bursuc, R. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 275 - 276
  • [30] Treatment of rheumatoid arthritis with anti-TNF-alpha agents: A reappraisal
    Caporali, Roberto
    Pallavicini, Francesca Bobbio
    Filippini, Matteo
    Gorla, Roberto
    Marchesoni, Antonio
    Favalli, Ennio Giulio
    Sarzi-Puttini, Piercarlo
    Atzeni, Fabiola
    Montecucco, Carlornaurizio
    AUTOIMMUNITY REVIEWS, 2009, 8 (03) : 274 - 280
12345